西部牧业(300106) - 2024 Q3 - 季度财报

Financial Performance - Revenue for Q3 2024 was CNY 249,659,813.67, a decrease of 17.52% compared to the same period last year[2] - Net profit attributable to shareholders was a loss of CNY 7,113,101.14, an increase in loss of 70.70% year-over-year[2] - Net profit excluding non-recurring items was a loss of CNY 11,863,481.16, an increase in loss of 57.13% year-over-year[2] - Total operating revenue for Q3 2024 was 702,155,915.23 CNY, a decrease of 19.7% compared to 875,562,589.43 CNY in the same period last year[13] - Net profit for Q3 2024 was -38,977,739.93 CNY, compared to a net profit of 2,019,953.27 CNY in Q3 2023, indicating a significant decline[13] - The total comprehensive income for the period was -¥38,977,739.93, compared to ¥2,019,953.27 in the previous period, indicating a significant decline[14] - The basic and diluted earnings per share were both -¥0.1968, worsening from -¥0.1002 in the same period last year[14] Cash Flow - Cash flow from operating activities for the year-to-date increased by 151.25% to CNY 14,052,704.82[5] - Cash inflow from operating activities was ¥763,938,634.78, down 10.9% from ¥857,128,111.55 in the previous year[15] - Cash outflow from operating activities totaled ¥749,885,929.96, a decrease of 15.2% compared to ¥884,550,203.03 last year[15] - The net cash flow from operating activities was ¥14,052,704.82, a decline from ¥27,422,091.48 in the previous period[15] - Cash inflow from investing activities was ¥454,678.00, up from ¥179,222.50 in the previous year[15] - The net cash flow from investing activities was -¥15,568,790.68, an improvement from -¥33,019,368.28 last year[15] - Cash inflow from financing activities was ¥157,733,076.00, down from ¥175,000,000.00 in the previous year[16] - The net cash flow from financing activities was -¥22,560,929.64, worsening from -¥7,097,748.34 in the same period last year[16] - The ending cash and cash equivalents balance was ¥283,089,600.19, slightly up from ¥275,227,607.45 in the previous year[16] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,170,044,029.96, a decrease of 2.75% from the end of the previous year[2] - The company's total assets decreased to 1,170,044,029.96 CNY from 1,203,154,298.58 CNY at the beginning of the period, a reduction of approximately 2.7%[12] - The total liabilities increased to 561,093,364.28 CNY from 526,213,482.73 CNY, reflecting a rise of about 6.6%[12] - The company's equity attributable to shareholders decreased to 499,705,836.31 CNY from 541,291,895.42 CNY, a decline of approximately 7.7%[12] - Shareholders' equity attributable to the parent company was CNY 499,705,836.31, down 7.68% from the previous year-end[2] - The total current assets decreased from 700,716,446.54 to 684,439,351.05, a decline of approximately 2.3%[10] Investments and Expenses - R&D expenses increased by 86.24% year-to-date, reflecting increased investment in product development[5] - Research and development expenses for Q3 2024 were 3,726,385.84 CNY, up from 2,000,802.66 CNY in the previous year, representing an increase of 86.1%[13] - Non-operating income decreased by 44.92% year-to-date, indicating a reduction in other income sources[5] - Long-term equity investments decreased from 41,971,801.21 to 30,003,110.83, a decline of about 28.5%[10] Shareholder Information - The total number of common shareholders at the end of the reporting period is 26,409[7] - Xinjiang Tiande Biological Co., Ltd. holds 41.82% of the shares, totaling 88,378,171 shares[9] - The company completed the transfer of 41.82% of shares from Shihezi State-owned Assets Management Company to Xinjiang Tiande Biological Co., Ltd. on September 6, 2024[9] - The company’s actual controller remains the State-owned Assets Supervision and Administration Commission of the Eighth Division of the Xinjiang Production and Construction Corps[9] - The company has no plans that would adversely affect its normal production and operations following the change in controlling shareholder[9] Accounts and Inventory - Accounts receivable increased from 208,651,515.81 to 238,719,885.81, representing a growth of about 14.4%[10] - Inventory decreased from 106,451,291.87 to 89,644,437.11, a reduction of approximately 15.8%[10] - The company reported a significant increase in accounts payable, rising to 171,188,087.03 CNY from 134,543,185.08 CNY, an increase of 27.2%[12] - Deferred income tax assets increased to 10,361,871.06 CNY from 9,200,290.58 CNY, indicating a growth of 12.6%[12] Retained Earnings - The company’s retained earnings showed a negative balance of -354,140,252.68 CNY, worsening from -312,554,193.57 CNY at the beginning of the period[12]